Psych Capital Changes Name To Shortwave Life Sciences | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – June 7, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland”), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles to the legal,…

Mydecine Receives Management Cease Trade Order | Psychedelic Invest

VANCOUVER, British Columbia, May 2, 2024 (TheNewswire) — Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has received a temporary

May 3, 2024

Clene’s FDA update; JCR ends ties with Takeda, partners with AstraZeneca; Gilead ups stake in Hookipa

Plus, news on Lyndra Therapeutics, Hadean Capital, Barinthus Bio, Shattuck Labs and Inventiva. Clene Nanomedicine’s roadblock: The company, which is developing a gold nanocrystal-based drug

December 22, 2023

McGill study sheds light on delusion patterns in youth psychosis

New findings from McGill University researchers could help clinicians understand the course of delusions in youth and young adults that signal the need for a

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.